{"id":60656,"date":"2024-02-28T07:01:04","date_gmt":"2024-02-28T07:01:04","guid":{"rendered":"https:\/\/medsname.com\/valprol-cr\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"valprol-cr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/valprol-cr\/","title":{"rendered":"Valprol-CR"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Valprol-CR?<\/h3>\n<p style=\"margin:0;\"><strong>Valprol-CR<\/strong> or\u00e1lis <strong>controlled-release tablet<\/strong> from Intas Pharmaceuticals containing <strong>sodium valproate + valproic acid<\/strong> &mdash; a broad-spectrum anti-epileptic, mood stabiliser and migraine-prophylaxis drug. Available in <strong>200 mg and 750 mg<\/strong> CR strengths. Used for: <strong>t\u00f6bbf\u00e9le epilepszi\u00e1s roham t\u00edpusn\u00e1l<\/strong> (\u00e1ltal\u00e1nos tonikus-kl\u00f3nikus, absence, myoklonikus, parci\u00e1lis), <strong>akut m\u00e1ni\u00e1s epiz\u00f3dok kezel\u00e9s\u00e9ben bipol\u00e1ris I zavarban.<\/strong>, \u00e9s <strong>migr\u00e9n megel\u0151z\u00e9s\u00e9re<\/strong>. Adult dosing: 600&ndash;2,500 mg\/day in divided doses. Take with or after food to reduce GI upset. <strong>FDA terhess\u00e9gi kateg\u00f3ria X migr\u00e9nre, D kateg\u00f3ria epilepszi\u00e1ra \u2014 az egyik legs\u00falyosabban teratog\u00e9n gy\u00f3gyszer a rutin klinikai gyakorlatban. K\u00f6telez\u0151 monitoroz\u00e1s: alapv\u00e9rk\u00e9p + periodikus m\u00e1jfunkci\u00f3 vizsg\u00e1lat, teljes v\u00e9rk\u00e9p, amm\u00f3nia szint ha t\u00fcnetek vannak. Gyakori mell\u00e9khat\u00e1sok: h\u00e1nyinger, \u00e1lmoss\u00e1g, remeg\u00e9s, s\u00falygyarapod\u00e1s, hajhull\u00e1s. Soha ne hagyd abba hirtelen \u2014 status epilepticus kock\u00e1zat.<\/strong> &mdash; one of the most teratogenic drugs in routine clinical use. Women of childbearing potential need explicit pregnancy-prevention counselling and should usually avoid valproate unless other options have failed. Mandatory monitoring: <strong>baseline + periodic LFTs, FBC, ammonia level if symptomatic<\/strong>. Never stop abruptly &mdash; abrupt discontinuation can precipitate status epilepticus.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<h2 class=\"wp-block-heading\">What Is Valprol-CR?<\/h2>\n<p>Valprol-CR is an oral controlled-release tablet from Intas Pharmaceuticals containing <strong>sodium valproate<\/strong> in combination with <strong>valproic acid<\/strong> (the same active molecule, different salt form &mdash; in solution they are equivalent). The CR (controlled-release) formulation gradually releases the active over 12&ndash;24 hours, allowing once-daily or twice-daily dosing instead of the three-or-four-times-daily schedule needed with immediate-release valproate.<\/p>\n<p>Valproate is one of the oldest and most broad-spectrum anti-epileptic drugs in use. It is licensed for multiple seizure types in epilepsy, acute mania in bipolar I disorder, and migraine prophylaxis. The CR formulation is preferred for adults requiring sustained 24-hour drug levels &mdash; particularly those who experience peak-related side effects (drowsiness, tremor) on immediate-release valproate.<\/p>\n<h2 class=\"wp-block-heading\">How Does Valprol-CR Work?<\/h2>\n<p>Sodium valproate has multiple complementary mechanisms that together produce its broad-spectrum anti-seizure and mood-stabilising effects:<\/p>\n<ul>\n<li><strong>Fesz\u00fclts\u00e9gf\u00fcgg\u0151 n\u00e1triumcsatorna-blokkol\u00e1s<\/strong> &mdash; reduces high-frequency neuronal firing, the basis of its anti-seizure effect on partial and generalised tonic-clonic seizures.<\/li>\n<li><strong>T-t\u00edpus\u00fa kalciumcsatorna-g\u00e1tl\u00e1s<\/strong> &mdash; particularly relevant to absence seizures, where T-type calcium currents in thalamocortical neurons drive the spike-wave pattern.<\/li>\n<li><strong>GABAerg fokoz\u00e1s<\/strong> &mdash; raises brain GABA concentration through inhibition of GABA-degrading enzymes (GABA-T and succinic semialdehyde dehydrogenase) and increased GABA synthesis.<\/li>\n<li><strong>NMDA-receptor modul\u00e1ci\u00f3<\/strong> &mdash; reduces excitatory glutamate transmission.<\/li>\n<\/ul>\n<p>A kombin\u00e1lt hat\u00e1s sz\u00e9les ter\u00e1pi\u00e1s spektrumot eredm\u00e9nyez k\u00fcl\u00f6nb\u00f6z\u0151 rohamt\u00edpusokra, hangulatstabiliz\u00e1l\u00f3 aktivit\u00e1st bipol\u00e1ris I zavarban, \u00e9s migr\u00e9n megel\u0151z\u00e9st a kortik\u00e1lis-terjed\u00e9si-depresszi\u00f3 g\u00e1tl\u00e1s\u00e1n kereszt\u00fcl.<\/p>\n<h2 class=\"wp-block-heading\">Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n<ul>\n<li><strong>Epilepszia \u2014 \u00e1ltal\u00e1nos tonikus-klonikus rohamok<\/strong> (els\u0151 vonalbeli)<\/li>\n<li><strong>Epilepszia \u2014 abszencia rohamok<\/strong> (first-line, especially in childhood and juvenile-onset)<\/li>\n<li><strong>Epilepszia \u2014 mioklonusos rohamok<\/strong> (els\u0151 vonalbeli kezel\u00e9s juvenilis mioklonusos epilepszi\u00e1ban)<\/li>\n<li><strong>Epilepszia \u2014 parci\u00e1lis (f\u00f3k\u00e1lis) rohamok<\/strong> (m\u00e1sodlagos generaliz\u00e1l\u00f3d\u00e1ssal vagy an\u00e9lk\u00fcl)<\/li>\n<li><strong>Lennox-Gastaut szindr\u00f3ma<\/strong> \u00e9s egy\u00e9b vegyes rohamt\u00edpusok<\/li>\n<li><strong>Bipol\u00e1ris I. zavar \u2014 akut m\u00e1ni\u00e1s epiz\u00f3d<\/strong> (FDA \u00e1ltal j\u00f3v\u00e1hagyott monoter\u00e1pia)<\/li>\n<li><strong>Bipol\u00e1ris I. zavar \u2014 karbantart\u00f3 ter\u00e1pia<\/strong> (off-label, sz\u00e9les k\u00f6rben haszn\u00e1lt)<\/li>\n<li><strong>Migr\u00e9n megel\u0151z\u00e9s<\/strong> in adults (FDA-approved when migraines are frequent and disabling)<\/li>\n<li><strong>Off-label alkalmaz\u00e1s:<\/strong> behavioural agitation in dementia (no longer recommended &mdash; mortality signal), aggression and impulse control, neuropathic pain<\/li>\n<\/ul>\n<p>Valprol-CR is <strong>nem<\/strong> first-line for: women of childbearing potential who could become pregnant (because of teratogenicity), pure absence seizures in young children if ethosuximide is available (cleaner safety), or generalised anxiety \/ unipolar depression. <strong>Behavioural agitation in dementia is no longer a recommended use<\/strong> &mdash; observational data suggest increased mortality, similar to the antipsychotic-in-dementia signal.<\/p>\n<h2 class=\"wp-block-heading\">Valprol-CR Dosage and How to Take<\/h2>\n<p>Valprol-CR comes at <strong>200 mg<\/strong> \u00e9s <strong>750 mg<\/strong> controlled-release strengths.<\/p>\n<p><strong>Szabv\u00e1nyos feln\u0151tt adagol\u00e1s indik\u00e1ci\u00f3 szerint:<\/strong><\/p>\n<ul>\n<li><strong>Epilepszia:<\/strong> Start 600 mg\/day (300 mg twice daily). Increase by 200 mg every 3 days based on seizure control. Maintenance 1,000&ndash;2,000 mg\/day in 1&ndash;2 divided doses. Maximum 2,500 mg\/day.<\/li>\n<li><strong>Bipol\u00e1ris I (akut m\u00e1ni\u00e1s epiz\u00f3d):<\/strong> Start 750 mg\/day in divided doses; increase rapidly to achieve serum level 50&ndash;125 &micro;g\/mL. Maintenance 1,000&ndash;2,500 mg\/day.<\/li>\n<li><strong>Migr\u00e9n megel\u0151z\u00e9se:<\/strong> Start 250 mg twice daily; increase to 500&ndash;1,000 mg\/day if needed. Many patients respond at 500 mg\/day.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">How to Take Valprol-CR Properly<\/h3>\n<ol>\n<li><strong>Szedje \u00e9tkez\u00e9s k\u00f6zben vagy ut\u00e1na.<\/strong> This is the single biggest factor in GI tolerability. Empty-stomach dosing causes nausea, dyspepsia and abdominal pain in most patients.<\/li>\n<li><strong>V\u00edzben t\u00f6rt\u00e9n\u0151 lenyel\u00e9sre.<\/strong> Do NOT crush, split, or chew controlled-release tablets &mdash; this destroys the controlled-release mechanism and causes a dose dump that produces severe peak-related side effects (drowsiness, tremor, GI upset).<\/li>\n<li><strong>Twice daily for most adults<\/strong>, ideally morning + evening 12 hours apart. Once-daily dosing (full daily dose at bedtime) is reasonable for migraine prophylaxis at 500&ndash;1,000 mg\/day.<\/li>\n<li><strong>Legyen k\u00f6vetkezetes az id\u0151z\u00edt\u00e9sben.<\/strong> Missed doses produce noticeable trough levels. If a dose is missed and remembered within 6 hours, take it. If &gt;6 hours, skip and resume normally &mdash; do not double-dose.<\/li>\n<li><strong>Monitoroz\u00e1si \u00fctemterv:<\/strong> baseline LFTs (AST, ALT, GGT), full blood count, and platelet count <strong>before starting<\/strong>. Repeat at <strong>1 month<\/strong>, <strong>; ha nem figyelhet\u0151 meg v\u00e1ltoz\u00e1s tests\u00falyban, der\u00e9k ker\u00fcletben vagy \u00e9tkez\u00e9si szok\u00e1sokban, szak\u00edtsa meg a szed\u00e9st \u00e9s fontolja meg enged\u00e9lyezett alternat\u00edv\u00e1kat. Hagyom\u00e1nyos ajurv\u00e9d gyakorlatban a kezel\u00e9s \u00e1ltal\u00e1ban 3\u20136 h\u00f3napig tart.<\/strong>, <strong>6 h\u00f3napot<\/strong>, then annually. Check ammonia level if patient develops drowsiness, confusion or vomiting.<\/li>\n<li><strong>Ter\u00e1pi\u00e1s gy\u00f3gyszer-monitoroz\u00e1s:<\/strong> serum valproate trough level is useful in epilepsy (target 50&ndash;100 &micro;g\/mL) and bipolar (target 50&ndash;125 &micro;g\/mL). Not routinely needed for migraine prophylaxis.<\/li>\n<li><strong>Soha ne hagyja abba hirtelen.<\/strong> Az epilepszi\u00e1ban t\u00f6rt\u00e9n\u0151 hirtelen abbahagy\u00e1s <strong>status epilepticus<\/strong> (medical emergency) even in patients who have been seizure-free for years. Taper over 2&ndash;6 weeks under medical supervision when discontinuing.<\/li>\n<li><strong>Terhess\u00e9gmegel\u0151z\u00e9s<\/strong> (women of childbearing potential): use reliable contraception throughout treatment. Discuss alternative drugs if pregnancy is a possibility &mdash; valproate is one of the most teratogenic drugs in routine clinical use.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Valprol-CR<\/h2>\n<p><strong>Gyakori (gyakran d\u00f3zisf\u00fcgg\u0151, lassabb titr\u00e1l\u00e1ssal enyh\u00fclhet):<\/strong><\/p>\n<ul>\n<li>H\u00e1nyinger, h\u00e1ny\u00e1s, gyomorf\u00e1jdalom, hasi f\u00e1jdalom<\/li>\n<li>\u00c1lomoss\u00e1g, f\u00e1rad\u00e9konys\u00e1g<\/li>\n<li>Tremor (fine, postural &mdash; often dose-dependent)<\/li>\n<li>Weight gain (10&ndash;20% of patients gain &gt;5 kg)<\/li>\n<li>Hair thinning or hair loss (reversible on discontinuation)<\/li>\n<li>Hasmen\u00e9s vagy sz\u00e9kreked\u00e9s<\/li>\n<li>Fokozott \u00e9tv\u00e1gy<\/li>\n<\/ul>\n<p><strong>Kevesebb gyakori, de fontos:<\/strong><\/p>\n<ul>\n<li>Thrombocytopenia (low platelet count) &mdash; usually mild and dose-related; check FBC every visit<\/li>\n<li>Hyperammonaemic encephalopathy &mdash; drowsiness, confusion, vomiting; can occur with normal LFTs; check ammonia level if suspected<\/li>\n<li>Polycystic ovary syndrome features in women &mdash; hyperandrogenism, menstrual irregularity, weight gain<\/li>\n<li>Increased liver enzymes (often asymptomatic)<\/li>\n<li>Hasny\u00e1lmirigy-gyullad\u00e1s (ritka, de \u00e9letvesz\u00e9lyes)<\/li>\n<li>Kognit\u00edv lassul\u00e1s, mem\u00f3riazavarok<\/li>\n<\/ul>\n<p><strong>Ritka, de azonnali orvosi seg\u00edts\u00e9g sz\u00fcks\u00e9ges:<\/strong><\/p>\n<ul>\n<li><strong>Acute fulminant hepatic failure<\/strong> &mdash; particularly in children under 2 years on polypharmacy. Stop immediately if jaundice, severe vomiting or new lethargy develops.<\/li>\n<li><strong>Akut pancreatitis<\/strong> &mdash; severe abdominal pain, vomiting<\/li>\n<li><strong>Hiperammon\u00e9mi\u00e1s encephalopathia<\/strong> with normal LFTs &mdash; new confusion, drowsiness, vomiting<\/li>\n<li>S\u00falyos b\u0151rreakci\u00f3k (Stevens-Johnson szindr\u00f3ma, DRESS)<\/li>\n<li>Csontvel\u0151-supresszi\u00f3<\/li>\n<li>S\u00falyos v\u00e9rz\u00e9s trombocitopenia vagy v\u00e9rlemezkefunkci\u00f3-zavar miatt<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Figyelmeztet\u00e9sek \u00e9s el\u0151vigy\u00e1zatoss\u00e1g \u2014 KRITIKUS<\/h2>\n<ul>\n<li><strong>Pregnancy: ABSOLUTE CONTRAINDICATION for migraine (FDA Category X) and STRONG WARNING for epilepsy (Category D).<\/strong> Sodium valproate is one of the most potent human teratogens in routine clinical use. Risk of major congenital malformations (neural tube defects, craniofacial defects, cardiac defects, limb defects, hypospadias) is approximately <strong>10%<\/strong>, plus a 30&ndash;40% risk of significant neurodevelopmental impairment (lower IQ, autism spectrum disorder) in children exposed in utero. Use only if no other option is effective. Women of childbearing potential need: (1) explicit pregnancy-prevention counselling, (2) reliable contraception throughout treatment, (3) preconception folate supplementation 5 mg\/day if pregnancy is planned, (4) urgent specialist review if pregnancy occurs.<\/li>\n<li><strong>Hepatotoxicit\u00e1s:<\/strong> highest risk in children under 2 years on multiple anti-epileptics (rare in adult monotherapy). Stop immediately for jaundice, severe vomiting, lethargy, or worsening seizures.<\/li>\n<li><strong>Hasny\u00e1lmirigy-gyullad\u00e1s:<\/strong> rare but life-threatening; idiosyncratic, can occur at any time during treatment. Seek emergency care for severe abdominal pain.<\/li>\n<li><strong>Hyperammonaemic encephalopathy:<\/strong> can occur with normal LFTs &mdash; check ammonia level if patient develops drowsiness, confusion or vomiting on valproate.<\/li>\n<li><strong>Mitokondri\u00e1lis betegs\u00e9g (POLG mut\u00e1ci\u00f3k):<\/strong> absolute contraindication &mdash; valproate causes acute liver failure in this rare population. Genetic testing is appropriate before starting if there is family history of mitochondrial disease or unexplained liver disease.<\/li>\n<li><strong>Karbamid-ciklus zavarok:<\/strong> contraindication &mdash; valproate precipitates hyperammonaemic encephalopathy.<\/li>\n<li><strong>V\u00e9rz\u00e9si kock\u00e1zat:<\/strong> valproate impairs platelet function and may cause thrombocytopenia. Tell the surgeon and stop 1&ndash;2 weeks before elective surgery if possible.<\/li>\n<li><strong>Demens betegekn\u00e9l:<\/strong> off-label use for behavioural agitation is no longer recommended &mdash; observational data show increased mortality.<\/li>\n<li><strong>Soha ne hagyja abba hirtelen<\/strong> in epilepsy &mdash; can precipitate status epilepticus.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindications &mdash; Who Should NOT Take Valprol-CR<\/h2>\n<ul>\n<li>Pregnancy or planning pregnancy (especially for migraine prophylaxis &mdash; absolute contraindication)<\/li>\n<li>Known hypersensitivity to valproate or any tablet excipient<\/li>\n<li>S\u00falyos m\u00e1jk\u00e1rosod\u00e1s vagy akt\u00edv m\u00e1jbetegs\u00e9g<\/li>\n<li>Personal or family history of severe hepatic dysfunction caused by drugs<\/li>\n<li>Mitochondrial disease (especially POLG mutations)<\/li>\n<li>Karbamid-ciklus zavarok<\/li>\n<li>Akut porfiria<\/li>\n<li>Children under 2 years (especially on polypharmacy &mdash; high hepatotoxicity risk)<\/li>\n<li>Akt\u00edv hasny\u00e1lmirigy-gyullad\u00e1s<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kombin\u00e1lhat\u00f3<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Hat\u00e1s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Teend\u0151k<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Lamotrigin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Valproate doubles lamotrigine levels &mdash; markedly increased risk of severe rash and Stevens-Johnson syndrome<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce lamotrigine dose by 50% when combined; very slow titration. Specialist supervision.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Karbapenemek (meropenem, ertapenem, imipenem)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Carbapenems dramatically reduce valproate levels &mdash; can precipitate seizures within days<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid combination. Use alternative antibiotic if valproate is essential.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Phenytoin, carbamazepine, phenobarbital (other AEDs)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Bidirectional protein-binding and metabolism interactions &mdash; unpredictable effects on both drugs<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mindk\u00e9t szer szintj\u00e9nek monitoroz\u00e1sa; szakfel\u00fcgyelet sz\u00fcks\u00e9ges.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aspirin (nagy d\u00f3zisban), NSAID-k<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Displace valproate from albumin; increase free fraction and toxicity<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ker\u00fclje a nagy d\u00f3zis\u00fa aspirin szed\u00e9s\u00e9t. Figyelje a valpro\u00e1t mell\u00e9khat\u00e1sait.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin, anticoagulants<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Increased anticoagulant effect (displacement) and platelet inhibition by valproate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor INR more frequently. Watch for bleeding.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Topiramate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Increased risk of hyperammonaemia and encephalopathy<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Check ammonia level if symptoms develop.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alkohol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Addit\u00edv CNS depresszi\u00f3 \u00e9s hepatotoxicit\u00e1s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Limit to occasional small amounts; avoid binge drinking.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombin\u00e1lt fogamz\u00e1sg\u00e1tl\u00f3 tabletta<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">No significant interaction (unlike many other AEDs)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">A kombin\u00e1lt fogamz\u00e1sg\u00e1tl\u00f3 tabletta hat\u00e9konys\u00e1ga v\u00e1ltozatlan. Megb\u00edzhat\u00f3 fogamz\u00e1sg\u00e1tl\u00e1s k\u00f6telez\u0151 a teratogenit\u00e1s miatt.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Benzodiazepinek<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Addit\u00edv CNS depresszi\u00f3<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid routine combination; use lowest doses if combined.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1si utas\u00edt\u00e1sok<\/h2>\n<ul>\n<li>Szobah\u0151m\u00e9rs\u00e9kleten t\u00e1rolja, <strong>15\u201325\u00b0C<\/strong>. V\u00e9dje a f\u00e9nyt\u0151l \u00e9s nedvess\u00e9gt\u0151l.<\/li>\n<li>A tablett\u00e1kat az eredeti blistercsomagol\u00e1sban tartsa haszn\u00e1latig.<\/li>\n<li>Ne t\u00e1rolja a f\u00fcrd\u0151szob\u00e1ban \u2014 a p\u00e1ratartalom cs\u00f6kkenti a polcon l\u00e9v\u0151 id\u0151t.<\/li>\n<li>Keep out of reach of children &mdash; valproate is highly teratogenic and accidental ingestion by a pregnant household member is a serious risk.<\/li>\n<li>Ne haszn\u00e1lja a lej\u00e1rati d\u00e1tum lej\u00e1rta ut\u00e1n.<\/li>\n<li>A fel nem haszn\u00e1lt tablett\u00e1kat gy\u00f3gyszert\u00e1rba sz\u00e1ll\u00edtsa a megfelel\u0151 \u00e1rtalmatlan\u00edt\u00e1s \u00e9rdek\u00e9ben.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k a MedsBase-en<\/h2>\n<p>Other medications stocked for epilepsy, bipolar disorder and migraine prophylaxis:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/product-category\/neurological-conditions-and-epilepsy\/\">Browse all neurological + epilepsy medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/product-category\/mental-health-and-psychiatric-medications\/\">Browse all mental health and psychiatric medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/product-category\/anti-migraine\/\">B\u00f6ng\u00e9sszen a migr\u00e9n elleni gy\u00f3gyszerek k\u00f6z\u00f6tt<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">What conditions is Valprol-CR used for?<\/h3>\n<p>Valprol-CR (sodium valproate + valproic acid) is licensed for: <strong>t\u00f6bbf\u00e9le epilepszi\u00e1s roham t\u00edpusn\u00e1l<\/strong> (\u00e1ltal\u00e1nos tonikus-kl\u00f3nikus, absence, myoklonikus, parci\u00e1lis), <strong>akut m\u00e1ni\u00e1s epiz\u00f3dok kezel\u00e9s\u00e9ben bipol\u00e1ris I zavarban.<\/strong>, \u00e9s <strong>migr\u00e9n megel\u0151z\u00e9s\u00e9re<\/strong> in adults. It is one of the broadest-spectrum anti-epileptic drugs available. Off-label uses include neuropathic pain and behavioural agitation in some psychiatric conditions, but it is no longer recommended for behavioural agitation in dementia (mortality signal in observational data).<\/p>\n<h3 class=\"wp-block-heading\">Why is Valprol-CR so dangerous in pregnancy?<\/h3>\n<p>Sodium valproate is one of the most teratogenic drugs in routine clinical use. In-utero exposure carries approximately <strong>10% kock\u00e1zatot jelent a s\u00falyos velesz\u00fcletett rendelleness\u00e9gekre<\/strong> (neural tube defects, cardiac defects, craniofacial defects, hypospadias, limb defects) plus a <strong>30\u201340% kock\u00e1zatot jelent\u0151s neurofejl\u0151d\u00e9si k\u00e1rosod\u00e1sra<\/strong> (alacsonyabb IQ, autizmus spektrum zavar). A migr\u00e9n megel\u0151z\u00e9s\u00e9re az FDA <strong>Pregnancy Category X (absolute contraindication)<\/strong>; for epilepsy Category D (use only if benefit outweighs the substantial fetal risk and no other option is available). Women of childbearing potential need explicit counselling, reliable contraception, and 5 mg\/day folate before any planned pregnancy.<\/p>\n<h3 class=\"wp-block-heading\">Why must I never stop Valprol-CR abruptly?<\/h3>\n<p>Epilepszi\u00e1ban a hirtelen abbahagy\u00e1s <strong>status epilepticus<\/strong> &mdash; a medical emergency where seizures do not stop spontaneously, with significant mortality if untreated. This can happen even in patients who have been seizure-free for years. Always taper over 2&ndash;6 weeks under medical supervision when discontinuing. The same caution applies to bipolar maintenance therapy &mdash; abrupt discontinuation can precipitate a manic relapse.<\/p>\n<h3 class=\"wp-block-heading\">What blood tests do I need on Valprol-CR?<\/h3>\n<p><strong>Kezd\u00e9s el\u0151tt:<\/strong> liver function tests (AST, ALT, GGT), full blood count including platelet count, baseline weight, fasting glucose. <strong>Kezel\u00e9s alatt:<\/strong> repeat LFTs and FBC at 1 month, 3 months, 6 months, then annually. <strong>Ha rosszul \u00e9rzi mag\u00e1t:<\/strong> check ammonia level if any new drowsiness, confusion or vomiting (hyperammonaemic encephalopathy can occur with normal LFTs). For epilepsy, periodic serum valproate trough level (target 50&ndash;100 &micro;g\/mL).<\/p>\n<h3 class=\"wp-block-heading\">Why can I not crush or split Valprol-CR tablets?<\/h3>\n<p>The CR (controlled-release) coating is what produces the sustained 12&ndash;24 hour drug release. Crushing or splitting destroys the coating and causes a &#8220;dose dump&#8221; &mdash; the entire dose is absorbed within 2&ndash;3 hours, producing very high peak levels with severe drowsiness, tremor, GI upset and sometimes hyperammonaemic encephalopathy. If a smaller dose is needed, use immediate-release valproate or step down to the 200 mg CR strength rather than splitting a 750 mg CR tablet.<\/p>\n<h3 class=\"wp-block-heading\">Will Valprol-CR cause weight gain or hair loss?<\/h3>\n<p>Mindkett\u0151 gyakori. <strong>S\u00falygyarapod\u00e1s<\/strong> affects 10&ndash;20% of patients (usually 5&ndash;10 kg over the first 6&ndash;12 months) and is driven by increased appetite plus metabolic effects. Mitigate with consistent diet and exercise. <strong>Hair thinning or hair loss<\/strong> legfeljebb 10%-ban fordul el\u0151, \u00e1ltal\u00e1ban az els\u0151 3\u20136 h\u00f3napban kezd\u0151dik, \u00e9s d\u00f3ziscs\u00f6kkent\u00e9s vagy abbahagy\u00e1s ut\u00e1n visszaford\u00edthat\u00f3. Cink \u00e9s szel\u00e9n kieg\u00e9sz\u00edt\u00e9s n\u00e9ha alkalmazhat\u00f3 (korl\u00e1tozott bizony\u00edt\u00e9k).<\/p>\n<h3 class=\"wp-block-heading\">Can Valprol-CR be used with lamotrigine?<\/h3>\n<p>Igen, de rendk\u00edv\u00fcli \u00f3vatoss\u00e1ggal. A valpro\u00e1t <strong>megdupl\u00e1zza a lamotrigin szintj\u00e9t<\/strong> by inhibiting its metabolism, sharply increasing the risk of severe rash and Stevens-Johnson syndrome &mdash; the most serious lamotrigine side effect. The combination is sometimes used (it has good cognitive and seizure-control properties) but lamotrigine must be started at <strong>a szok\u00e1sos adag fel\u00e9vel<\/strong> with a much slower up-titration (12-week protocol). Specialist supervision is essential.<\/p>\n<h3 class=\"wp-block-heading\">Why do certain antibiotics (carbapenems) interact so dangerously with Valprol-CR?<\/h3>\n<p>A karbapenem antibiotikumok (meropenem, ertapenem, imipenem) <strong>dr\u00e1maian cs\u00f6kkentik a valpro\u00e1t szintj\u00e9t<\/strong> &mdash; sometimes by &gt;90% within 1&ndash;3 days &mdash; through a poorly understood mechanism that may involve enterohepatic recirculation. The result is sudden loss of seizure control even in patients on stable therapeutic levels for years. <strong>Ker\u00fclje ezt a kombin\u00e1ci\u00f3t.<\/strong> If a patient on valproate needs a carbapenem (e.g. for hospital-acquired infection), switch the antibiotic to an alternative, OR switch the anti-epileptic before the carbapenem is started.<\/p>\n<h3 class=\"wp-block-heading\">Is Valprol-CR appropriate for behavioural agitation in dementia?<\/h3>\n<p><strong>No longer recommended.<\/strong> Off-label use of valproate for behavioural agitation in Alzheimer&#39;s and other dementias was common until observational studies suggested an <strong>increased mortality signal<\/strong>, similar to the signal that led to black-box warnings on antipsychotic use in dementia. Current guidelines favour non-pharmacological approaches first, then short-term low-dose risperidone or quetiapine if needed, with valproate reserved for very specific cases under specialist supervision.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/gabatop\/\">Gabatop<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/gabimax\/\">Gabimax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/xepar\/\">Xepar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tenof-em\/\">Tenof EM<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/cresar\/\">Cresar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Valprol-CR (Sodium valproate CR 200\u2013500 mg) \u2014 anticonvulsant mood stabiliser for epilepsy, bipolar mania, migraine prophylaxis. flatter level curve \u2014 twice-daily controlled-release.<\/p>","protected":false},"featured_media":60657,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3906,3468],"product_tag":[4677,4898,4899],"class_list":{"0":"post-60656","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_cat-neurological-conditions-and-epilepsy","10":"product_tag-sodium-valproate","11":"product_tag-valproic-acid","12":"product_tag-valprol-cr","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/60656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=60656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/60657"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=60656"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=60656"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=60656"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=60656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}